Exomind for Addiction Recovery
Exomind (rTMS) and addiction recovery — an emerging, actively researched area, presented carefully alongside established addiction psychiatry treatment.
Addiction psychiatry has well-established, evidence-based treatments — including medication-assisted treatment where appropriate, structured psychotherapy, and comprehensive relapse prevention planning — which remain the foundation of care. rTMS targeting brain reward circuits involved in craving and addiction is an actively researched, emerging area, with growing but still developing evidence across different substances.
As an Addiction Psychiatrist, Dr. Muhammad Shoaib Zafar presents rTMS for addiction carefully and honestly, as a potential complementary tool within a comprehensive, established addiction treatment programme, not a standalone or first-line treatment.
Current Research Across Substances
Research into rTMS for addiction has explored its potential to reduce cravings by targeting brain reward circuitry, with varying levels of evidence across different substances:
- Nicotine — rTMS received FDA clearance as an aid for smoking cessation in 2020, the most established addiction-related application
- Alcohol — an emerging area of research, with some studies suggesting reduced craving, though not yet an established, standard treatment
- Cocaine and Crystal Meth (stimulants) — active research area exploring effects on craving and relapse, still investigational
- Opioids — early-stage research exploring potential adjunctive benefit, alongside established medication-assisted treatment
- Cannabis — limited research specifically on rTMS for cannabis use disorder
- Behavioural addictions — preliminary research interest, particularly regarding shared reward-circuit mechanisms
Why Established Addiction Treatment Remains the Foundation
Given the seriousness of substance use disorders and the strength of existing evidence-based treatments, rTMS should be understood as a potential future complementary tool, not a replacement for established, comprehensive addiction psychiatry care, which remains the priority for every patient.
Frequently Asked Questions
Frequently Asked Questions
Is rTMS an established treatment for addiction?
Only for smoking cessation does rTMS currently have specific regulatory clearance; for other substances, it remains an emerging, actively researched area rather than a standard, established treatment.
Should I try rTMS instead of standard addiction treatment?
No, established addiction treatment, including medication-assisted treatment where appropriate and structured psychotherapy, should remain the foundation of care.
Expert Care
Dr. Muhammad Shoaib Zafar, as an Addiction Psychiatrist, integrates emerging research honestly within a comprehensive, established addiction treatment framework.
This page is provided for general educational purposes and does not replace an individual psychiatric assessment.
Common signs & symptoms
- Cravings for alcohol, opioids, stimulants, or other substances
- Difficulty maintaining abstinence
- Relapse despite motivation to stop
- Co-existing depression or anxiety alongside substance use
Treatment approach
- → Established, comprehensive addiction treatment remains the foundation of care
- → Medication-assisted treatment where appropriate to the substance involved
- → Motivational Interviewing and relapse prevention therapy
- → rTMS for craving reduction remains an emerging, actively researched area
Frequently asked questions
Is rTMS an established treatment for addiction?
Only for smoking cessation does rTMS currently have specific regulatory clearance; for other substances, it remains an emerging, actively researched area rather than a standard, established treatment.
Should I try rTMS instead of standard addiction treatment?
No, established addiction treatment, including medication-assisted treatment where appropriate and structured psychotherapy, should remain the foundation of care.